AI-generated summary
This communication discusses the challenges of managing oral mucositis during the COVID-19 pandemic and proposes an extraoral photobiomodulation protocol as an alternative for preventing and treating the condition in advanced cancer patients. The authors describe the approach as a way to limit infection risk by avoiding intraoral manipulation. The abstract presents this as a perspective and reflection rather than reporting a study with measured outcomes.
- Who or what was studied
- Advanced cancer patients with oral mucositis
- Limits stated in the abstract
- The abstract is a communication offering perspective and reflection, with no reported clinical data or outcome measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.